David Jin is the new finance chief of Fortress Biotech

Jul. 22, 2022 8:11 AM ETFortress Biotech, Inc. (FBIO)By: Deepa Sarvaiya, SA News Editor1 Comment
  • Fortress Biotech (NASDAQ:FBIO) appoints David Jin as CFO succeeding Robyn Hunter, effective August 16, 2022 and will also continue to serve as Head of Corporate Development.
  • Ms. Hunter will step down from the company after 11 years with the company to pursue external opportunities.
  • Mr. Jin has been a core member of the Fortress team since joining in 2020 and also serves as Interim Chief Executive Officer and Chief Financial Officer of Avenue Therapeutics (ATXI), a Fortress partner company.

Recommended For You

Comments (1)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.